Gene expression profile of steroid-induced necrosis of femoral head of rats

Calcified Tissue International

Volumn 89, Issue 4, 2011, Pages 271-284

  Tong, Peijian ^a   Wu, Chengliang ^b   Jin, Hongting ^b   Mao, Qiang ^b   Yu, Nanze ^b,c   Holz, Jonathan D ^d,e   Shan, Letian ^b   Liu, Hui ^b   Xiao, Luwei ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d UNIVERSITY OF ROCHESTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Gene chip; Gene expression profile; Osteonecrosis; Pathogenesis

Indexed keywords

STEROID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; FEMUR HEAD NECROSIS; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEROID INDUCED FEMUR HEAD NECROSIS; UNINDEXED SEQUENCE;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMUR HEAD NECROSIS; GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; MALE; MICROARRAY ANALYSIS; RATS; RATS, WISTAR; STEROIDS; TIME FACTORS;

EID: 82755160967     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9516-y     Document Type: Article

References (49)

1. Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M (2010) Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial. Pediatr Nephrol 25:877-882
2. Hodson EM, Alexander SI (2008) Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr 20: 145-150 (Pubitemid 351365703)
3. Tönshoff B, Höcker B, Weber LT (2005) Steroid withdrawal in pediatric and adult renal transplant recipients. Pediatr Nephrol 20:409-417 (Pubitemid 40309953)
4. Mont MA, Jones LC, Hungerford DS (2006) Nontraumatic osteoneeresis of the femoral head: ten years later. J Bone Joint Surg Am 88:1117-1132
5. Levasseur R (2008) Mechanisms of osteonecrosis. Joint Bone Spine 75:639-642
6. Parsons SJ, Steele N (2008) Osteonecrosis of the femoral head, part 2: options for treatment. Curr Orthop 22:349-358
7. Hungerford DS (2007) Treatment of osteonecrosis of the femoral head: everything's new. J Arthroplasty 22(4 suppl 1):S91-S94
8. Kerachian MA, Séguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121-128
9. Hadjigeorgiou G, Dardiotis E, Dardioti M, Karantanas A, Dimitroulias A, Malizos K (2008) Genetic association studies in osteonecrosis of the femoral head: mini review of the literature. Skeletal Radiol 37:1-7 (Pubitemid 350160505)
10. Glueck CJ, Freiberg RA, Wang P (2008) Heritable thrombophilia- hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res 466:1034-1040
11. Kim TH, Hong JM, Oh B, Cho YS, Lee JY, Kim HL, Shin ES, Lee JE, Park EK, Kim SY (2008) Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage 16:1060-1066
12. Kim TH, Hong JM, Lee JY, Oh B, Park EK, Lee CK, Bae SC, Kim SY (2008) Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage 16:287-291 (Pubitemid 351309178)
13. Lee HJ, Choi SJ, Hong JM, Lee WK, Baek JI, Kim SY, Park EK, Kim SY, Kim TH, Kim UK (2009) Association of a polymorphism in the intron 7 of the SREBF1 gene with osteonecrosis of the femoral head in Koreans. Ann Hum Genet 73:34-41
14. Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44:456-460 (Pubitemid 41511133)
15. Saha S, Ghosh P, Mitra D, Mukherjee S, Bhattacharya S, Roy SS (2007) Localization and thyroid hormone influenced expression of collagen II in ovarian tissue. Cell Physiol Biochem 19:67-76
16. Liu YF, Chen WM, Lin YF, Yang RC, Lin MW, Li LH, Chang YH, Jou YS, Lin PY, Su JS, Huang SF, Hsiao KJ, Fann CS, Hwang HW, Chen YT, Tsai SF (2005) Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Engl J Med 352:2294-2301 (Pubitemid 40740553)
17. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP9/gelatinase b is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422 (Pubitemid 28232085)
18. Barnes MG, Aronow BJ, Luyrink LK, Moroldo MB, Pavlidis P, Passo MH, Grom AA, Hirsch R, Giannini EH, Colbert RA, Glass DN, Thompson SD (2004) Gene expression in juvenile arthritis and spondyloarthropathy: proangiogenic ELR? chemokine genes relate to course of arthritis. Rheumatology 43:973-979 (Pubitemid 39144443)
19. Magnussen RA, Guilak F, Vail TP (2005) Articular cartilage degeneration in post collapse osteonecrosis of femoral head. Radiographic staging microscopic grading, and histologic changes. J Bone Joint Surg Am 87:1272-1277 (Pubitemid 40756628)
20. Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis: a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg (Br) 86:1209-1213 (Pubitemid 39545614)
21. Eberhardt AW, Yeager-Jones A, Blair HC (2001) Regional trabecular bone matrix degeneration and osteocyte death in femoral of glucocorticoid treated rabbits. Endocrinology 142:1333-1340 (Pubitemid 32202846)
22. Radke S, Battmann A, Jatzke S, Eulert J, Jakob F, Schutze N (2006) Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 24:945-952 (Pubitemid 43804929)
23. Karsenty G (2000) How many factors are required to remodel bone? Nat Med 6:970-971
24. Tanaka S, Nakamura I, Inoue J, Oda H, Nakamura K (2003) Signal transduction pathways regulating osteoclast differentiation and function. J Bone Miner Metab 21:123-133 (Pubitemid 41184293)
25. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357 (Pubitemid 30649812)
26. Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S (2004) Oxidative stress and vascular permeability in steroidinduced osteonecrosis model. J Orthop Sci 9:509-515 (Pubitemid 39410181)
27. Lu PZ, Lai CY, Chan WH (2008) Caffeine induces cell death via activation of apoptotic signal and inactivation of survival signal in human osteoblasts. Int J Mol Sci 9:698-718
28. Choi EM, Kim GH, Lee YS (2009) Protective effects of dehydrocostus lactone against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells. Toxicol In Vitro 23:862-867
29. Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH (2004) Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 301:119-127 (Pubitemid 39504965)
30. Yamasaki N, Tsuboi H, Hirao M, Nampei A, Yoshikawa H, Hashimoto J (2009) High oxygen tension prolongs the survival of osteoclast precursors via macrophage colony-stimulating factor. Bone 44:71-79
31. Kim HK, Morgan-Bagley S, Kostenuik P (2006) RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis. J Bone Miner Res 21:1946-1954 (Pubitemid 44851571)
32. Saito S, Ohzono K, Ono K (1992) Early arteriopathy and postulated pathogenesis of the femoral head: the intracapital artedoteriles. Clin Orthop Relat Res 277:98-110
33. Jones JP Jr (1992) Intravascular coagulation and osteonecrosis. Clin Orthop Relat Res 277:41-53
34. Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T, Yoshizawa S, Murai K, Ueda A, Haruta Y, Ohta A (2006) Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus 15: 354-357 (Pubitemid 44032710)
35. Jones JP Jr, Sakovich L (1996) Fat embolism of bone. A roentgenographic and histological investigation, with use of intraarterial lipiodol, in rabbits. J Bone Joint Surg Am 48:149-164
36. Li X, Jin L, Cui Q, Wang GJ, Balian G (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16:101-108 (Pubitemid 40193225)
37. Motomura G, Yamamoto T, Miyanishi K, Yamashita A, Sueishi K, Iwamoto Y (2005) Bone marrow fat-cell enlargement in early steroid-induced osteonecrosis: a histomorphometric study of autopsy cases. Pathol Res Pract 200:807-811 (Pubitemid 40220963)
38. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, Iwamoto Y (2002) Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30:185-190 (Pubitemid 34044317)
39. Glueck CJ, Freiberg RA, Oghene J, Fontaine RN, Wang P (2007) Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. J Bone Joint Surg Am 89:2460-2468 (Pubitemid 350086337)
40. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628 (Pubitemid 29289424)
41. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421-424 (Pubitemid 30367411)
42. Kim TH, Hong JM, Park EK, Kim SY (2007) Peroxisome proliferator- activated receptor-c gene polymorphisms are not associated with osteonecrosis of the femoral head in the Korean population. Mol Cells 24:388-393
43. Miksa M, Amin D, Wu R, Jacob A, Zhou M, Dong W, Yang WL, Ravikumar TS, Wang P (2008) Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response. Int J Mol Med 22:743-748
44. Igarashi A, Shibata Y, Yamauchi K, Osaka D, Takabatake N, Abe S, Inoue S, Kimura T, Yamaguchi Y, Ishizaki J, Hanasaki K, Kubota I (2009) Gly80Ser polymorphism of phospholipase A2-IID is associated with cytokine inducibility in a549 cells. Respiration 78:312-321
45. Granata F, Balestrieri B, Petraroli A, Giannattasio G, Marone G, Triggiani M (2003) Secretory phospholipases A2 as multivalent mediators of inflammatory and allergic disorders. Int Arch Allergy Immunol 131:153-163 (Pubitemid 36921053)
46. Silliman CC, Moore EE, Zallen G, Gonzalez R, Johnson JL, Elzi DJ, Meng X, Hanasaki K, Ishizaki J, Arita H, Ao L, England KM, Banerjee A (2002) Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion. Am J Physiol Cell Physiol 283:C1102-C1113
47. Cremasco V, Mantelli B, Lazzarin A, Biswas P (2009) Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serum. New Microbiol 32:125-128
48. Cox JH, Dean RA, Roberts CR, Overall CM (2008) Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. J Biol Chem 283:19389-19399
49. Tanaka S, Nakamura K, Takahasi N, Suda T (2005) Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208:30-49 (Pubitemid 41746383)